1,215 results on '"Heymann, Dominique"'
Search Results
2. Why are osteoporosis patients treated with antiresorptive therapies considered like oncology patients regarding their oral health care?
3. Drug-tolerant persister cells in cancer: the cutting edges and future directions
4. A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma
5. Advances in Osteosarcoma
6. Identification of MCM4 and PRKDC as new regulators of osteosarcoma cell dormancy based on 3D cell cultures
7. High glucose exposure drives intestinal barrier dysfunction by altering its morphological, structural and functional properties
8. Computational model combined with in vitro experiments to analyse mechanotransduction during mesenchymal stem cell adhesion
9. Pharmacological options in the treatment of osteogenesis imperfecta: A comprehensive review of clinical and potential alternatives
10. Circulating Tumor Cells and ctDNA in Sarcomas
11. Lipopolysaccharide-binding protein expression is associated to the metastatic status of osteosarcoma patients
12. FVIII at the crossroad of coagulation, bone and immune biology: Emerging evidence of biological activities beyond hemostasis
13. The P2RX7B splice variant modulates osteosarcoma cell behaviour and metastatic properties
14. The intratumoral microbiome: Characterization methods and functional impact
15. In vitro three-dimensional cell cultures for bone sarcomas
16. Three-dimensional in vitro culture models in oncology research
17. Author Correction: Osteosarcoma
18. Osteosarcoma
19. Development of prohibitin ligands against osteoporosis
20. Mammalian models of bone sarcomas
21. Liquid biopsy in bone sarcomas and identification of new biomarkers
22. N6-Adenosine Methylation of miRNA-200b-3p Influences Its Functionality and Is a Theranostic Tool
23. Bisphosphonates in common pediatric and adult bone sarcomas
24. Sphingolipid distribution at mitochondria-associated membranes (MAMs) upon induction of apoptosis
25. TH1579, MTH1 inhibitor, delays tumour growth and inhibits metastases development in osteosarcoma model
26. The Heterogeneity of Osteosarcoma: The Role Played by Cancer Stem Cells
27. FVIII regulates the molecular profile of endothelial cells: functional impact on the blood barrier and macrophage behavior
28. Genetically-achieved disturbances to the expression levels of TNFSF11 receptors modulate the effects of zoledronic acid on growing mouse skeletons
29. The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma
30. Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice
31. Dormant, quiescent, tolerant and persister cells: Four synonyms for the same target in cancer
32. Characterization of circulating tumor cells as a reflection of the tumor heterogeneity: myth or reality?
33. A Prospective Observational Cohort Study for Newly Diagnosed Osteosarcoma Patients in the UK: ICONIC Study Initial Results.
34. Osteoprotegerin
35. Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapy
36. Small animal models for the study of bone sarcoma pathogenesis:characteristics, therapeutic interests and limitations
37. Oral administration of edelfosine encapsulated lipid nanoparticles causes regression of lung metastases in pre-clinical models of osteosarcoma
38. Zoledronic Acid
39. Technical report: liquid overlay technique allows the generation of homogeneous osteosarcoma, glioblastoma, lung and prostate adenocarcinoma spheroids that can be used for drug cytotoxicity measurements
40. Osteoprotegerin regulates cancer cell migration through SDF-1/CXCR4 axis and promotes tumour development by increasing neovascularization
41. Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cells
42. Sarcoma treatment in the era of molecular medicine
43. Analysis of gap junctional intercellular communications using a dielectrophoresis-based microchip
44. Cancer stem cells in osteosarcoma
45. Inhibition of BET proteins and epigenetic signaling as a potential treatment for osteoporosis
46. Bone Morphogenetic Protein 2 and Transforming Growth Factor β1 Inhibit the Expression of the Proinflammatory Cytokine IL-34 in Rheumatoid Arthritis Synovial Fibroblasts
47. A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma
48. Meet the Editorial Board Membe
49. Severe compromise of preosteoblasts in a surgical mouse model of bisphosphonate-associated osteonecrosis of the jaw
50. Mesenchymal stem cells increase proliferation but do not change quiescent state of osteosarcoma cells: Potential implications according to the tumor resection status
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.